Announcement
James T. Joins Mavengity as a Medical Writer
With James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article
Posted in the last 24 hours
Fresh from the desks
Corporate Strategy
Software Companies Are Now Pricing the Work, Not the Worker
Workday, GitLab, and Figma have each moved off pure per-seat pricing and onto meters that charge for completed work. The market rewarded the companies that kept the most seat-like structure and punished the meters, and August's whipsaw is the gap between the two.
Markets
Unitree's Debut Priced Tesla's Promise
Unitree Robotics closed its Shanghai debut up 460 percent, at roughly 1,200 times earnings. That multiple isn't a price on Unitree's business, it's a price on Tesla's Optimus story, denominated in a different company's stock.
Interest Rates
Bessent's Buybacks Are Too Small to Fix the Yields They Warn About
The Treasury doubled its debt buyback size after the 30-year yield hit a two-decade high. The purchase itself is a rounding error against $32 trillion in debt, so the market's rally was a response to the message, not the money.
Banking
The Texas Bank Roll-Up Runs on Retirement Timetables
A former Veritex executive is rolling up small Texas community banks. Of six banks that fit his criteria, three never returned his call. The constraint on the deal flow isn't capital, it's the owners' retirement calendar.
Clinical Trials
The Melanoma Vaccine That Can't Be Made Until After Surgery
Moderna and Merck's personalized mRNA vaccine slowed melanoma's return in a phase 3 trial, but each dose is built from a specific patient's tumor and can't be made until weeks after surgery. That wait is part of the medicine, not a footnote.
Corporate Strategy
Google Paid $10 Million for the Archive of a Failed Airline
Google outbid an AI data company for Spirit Airlines' internal business archive, 100 million emails and more, stripped of passenger data. The sale reveals a structural quirk: complete corporate archives only reach the market after the company dies.
Markets
The U.S. Is the World's Diesel Supplier, and the World Sets Its Price
Diesel hit a record August average while gasoline stayed comparatively contained. The reason is that diesel is the world's most globally traded fuel, the U.S. is now its marginal supplier, and the world's shortage sets the American pump price.
Pharma Regulation
The New FOP Drug Saves What the Disease Hasn't Taken Yet
The FDA approved Pasatru, the first drug shown to reduce both new bone formation and flare-ups in FOP, the ultra-rare disease that turns muscle into a second skeleton. It preserves function, and its value depends on how early the disease is caught.
Interest Rates
The Market Shrugged at the Fed's Inflation Warning
The Fed's July minutes described elevated inflation and risks skewed to the upside, with the most dissents in a decade. Markets barely moved, because the long end had already priced the warning weeks in advance.
B2B Research
Most Popular Research Articles
Intent Data
Intent Data Providers For B2B
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
Knowledge Management
Knowledge Management Solutions
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
MDR
Managed Detection And Response Services
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
MDR Europe
Managed Detection And Response Services In Europe
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Manufacturing Tech
Manufacturing Technology Services
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Market Intelligence
Market And Competitive Intelligence Platforms
Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.
Open Banking
Open Banking Intermediaries
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Change Management
Organizational Change Management Services
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
PLM
Product Lifecycle Management Platforms For Discrete Manufacturers
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Announcements
News from Mavengity
Browse by topic
Where would you like to start?
Every article on Mavengity is written by a dedicated topic desk and checked against current market practice.
Insurance
Home, auto, life, and health coverage, explained clearly and checked against the fine print.
Browse InsuranceMortgage
Rates, refinancing, and first-time buyer strategy, without the jargon lenders assume you already know.
Browse MortgagePersonal Finance
Budgeting, saving, and everyday money habits that compound. No get-rich-quick promises.
Browse Personal FinanceLegal
Contracts, consumer rights, and disputes, explained so you know where you stand.
Browse LegalHealthcare & Medical
Health coverage and medical billing, broken down so surprise bills are less likely to surprise you.
Browse HealthcareResearch
Gartner and Forrester categories for B2B, translated into plain-English analysis for buyers, not analyst-subscription holders.
Browse Research
Why Mavengity
Editorial standards you can check
Independently researched
We start from public rate filings, regulator guidance, and lender disclosures, not marketing copy.
Plain-English explanations
If a term needs a footnote, we explain it in the sentence instead of hiding it in the fine print.
Straight, not slanted
We flag trade-offs and blind spots, not just the upside, so you get the full picture before you decide.
Written for readers, not lenders
Mavengity is reader-supported and editorially independent from the products we cover.